Please assess the completion status of the following clinical trial:

Trial Title: The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Be active duty United States Service member~2. Be between the ages of 18 and 50 years~3. Present to TQ Surgical within 24 hours of blast exposure.~4. Have complains consistent with possible TBI including hearing loss, dizziness, lightheadedness, cognitive difficulties, and/or had loss of consciousness.~5. Are not expressly excluded by the criteria listed below.~Exclusion Criteria:~1. Require urgent or emergent surgical procedures.~2. Will require medical evacuation to any level III or higher facility (other then to a level III for a CT scan only).~3. Has evidence of an open head wound.~4. Pregnant Females~5. The use, within the last seven days, of a nutritional supplement containing an anti-oxidant.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- 2 (Type: PLACEBO_COMPARATOR): control
- 1 (Type: EXPERIMENTAL): Active medicine

Based on this trial design, predict the completion outcome and termination type (if applicable).